Cargando…

Advanced maternal age: copy number variations and pregnancy outcomes

Objective: Adverse pregnancy outcomes are closely related to advanced maternal age (AMA; age at pregnancy ≥35 years). Little research has been reported on aneuploid abnormalities and pathogenic copy number variations (CNVs) affecting pregnancy outcomes in women with AMA. The purpose of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Luoyuan, Dong, Wenxu, Wu, Qinjuan, Huang, Xiaomin, Zeng, Xiaomei, Yang, Jing, Lu, Jiaojiao, Chen, Xunyan, Zheng, Xian, Fu, Xianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308028/
https://www.ncbi.nlm.nih.gov/pubmed/37396033
http://dx.doi.org/10.3389/fgene.2023.1206855
_version_ 1785066159346810880
author Cao, Luoyuan
Dong, Wenxu
Wu, Qinjuan
Huang, Xiaomin
Zeng, Xiaomei
Yang, Jing
Lu, Jiaojiao
Chen, Xunyan
Zheng, Xian
Fu, Xianguo
author_facet Cao, Luoyuan
Dong, Wenxu
Wu, Qinjuan
Huang, Xiaomin
Zeng, Xiaomei
Yang, Jing
Lu, Jiaojiao
Chen, Xunyan
Zheng, Xian
Fu, Xianguo
author_sort Cao, Luoyuan
collection PubMed
description Objective: Adverse pregnancy outcomes are closely related to advanced maternal age (AMA; age at pregnancy ≥35 years). Little research has been reported on aneuploid abnormalities and pathogenic copy number variations (CNVs) affecting pregnancy outcomes in women with AMA. The purpose of this study was to assess CNVs associated with AMA in prenatal diagnosis to determine the characteristics of pathogenic CNVs and assist with genetic counseling of women with AMA. Methods: Among 277 fetuses of women with AMA, 218 (78.7%) were isolated AMA fetuses and 59 (21.3%) were non-isolated AMA fetuses and showed ultrasound anomalies from January 2021 to October 2022. Isolated AMA was defined as AMA cases without sonographic abnormalities. Non-isolated AMA was defined as AMA cases with sonographic abnormalities such as sonographic soft markers, widening of the lateral ventricles, or extracardiac structural anomalies. The amniotic fluid cells underwent routine karyotyping followed by single nucleotide polymorphism array (SNP-array) analysis. Results: Of the 277 AMA cases, karyotype analysis identified 20 chromosomal abnormalities. As well as 12 cases of chromosomal abnormalities corresponded to routine karyotyping, the SNP array identified an additional 14 cases of CNVs with normal karyotyping results. There were five pathogenetic CNVs, seven variations of uncertain clinical significance (VOUS), and two benign CNVs. The detection rate of abnormal CNVs in non-isolated AMA cases was increasing (13/59; 22%) than in isolated AMA cases (13/218; 5.96%) (p < 0.001). We also determined that pathogenic CNVs affected the rate of pregnancy termination in women with AMA. Conclusion: Aneuploid abnormalities and pathogenic CNVs affect pregnancy outcomes in women with AMA. SNP array had a higher detection rate of genetic variation than did karyotyping and is an important supplement to karyotype analysis, which enables better informed clinical consultation and clinical decision-making.
format Online
Article
Text
id pubmed-10308028
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103080282023-06-30 Advanced maternal age: copy number variations and pregnancy outcomes Cao, Luoyuan Dong, Wenxu Wu, Qinjuan Huang, Xiaomin Zeng, Xiaomei Yang, Jing Lu, Jiaojiao Chen, Xunyan Zheng, Xian Fu, Xianguo Front Genet Genetics Objective: Adverse pregnancy outcomes are closely related to advanced maternal age (AMA; age at pregnancy ≥35 years). Little research has been reported on aneuploid abnormalities and pathogenic copy number variations (CNVs) affecting pregnancy outcomes in women with AMA. The purpose of this study was to assess CNVs associated with AMA in prenatal diagnosis to determine the characteristics of pathogenic CNVs and assist with genetic counseling of women with AMA. Methods: Among 277 fetuses of women with AMA, 218 (78.7%) were isolated AMA fetuses and 59 (21.3%) were non-isolated AMA fetuses and showed ultrasound anomalies from January 2021 to October 2022. Isolated AMA was defined as AMA cases without sonographic abnormalities. Non-isolated AMA was defined as AMA cases with sonographic abnormalities such as sonographic soft markers, widening of the lateral ventricles, or extracardiac structural anomalies. The amniotic fluid cells underwent routine karyotyping followed by single nucleotide polymorphism array (SNP-array) analysis. Results: Of the 277 AMA cases, karyotype analysis identified 20 chromosomal abnormalities. As well as 12 cases of chromosomal abnormalities corresponded to routine karyotyping, the SNP array identified an additional 14 cases of CNVs with normal karyotyping results. There were five pathogenetic CNVs, seven variations of uncertain clinical significance (VOUS), and two benign CNVs. The detection rate of abnormal CNVs in non-isolated AMA cases was increasing (13/59; 22%) than in isolated AMA cases (13/218; 5.96%) (p < 0.001). We also determined that pathogenic CNVs affected the rate of pregnancy termination in women with AMA. Conclusion: Aneuploid abnormalities and pathogenic CNVs affect pregnancy outcomes in women with AMA. SNP array had a higher detection rate of genetic variation than did karyotyping and is an important supplement to karyotype analysis, which enables better informed clinical consultation and clinical decision-making. Frontiers Media S.A. 2023-06-15 /pmc/articles/PMC10308028/ /pubmed/37396033 http://dx.doi.org/10.3389/fgene.2023.1206855 Text en Copyright © 2023 Cao, Dong, Wu, Huang, Zeng, Yang, Lu, Chen, Zheng and Fu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Cao, Luoyuan
Dong, Wenxu
Wu, Qinjuan
Huang, Xiaomin
Zeng, Xiaomei
Yang, Jing
Lu, Jiaojiao
Chen, Xunyan
Zheng, Xian
Fu, Xianguo
Advanced maternal age: copy number variations and pregnancy outcomes
title Advanced maternal age: copy number variations and pregnancy outcomes
title_full Advanced maternal age: copy number variations and pregnancy outcomes
title_fullStr Advanced maternal age: copy number variations and pregnancy outcomes
title_full_unstemmed Advanced maternal age: copy number variations and pregnancy outcomes
title_short Advanced maternal age: copy number variations and pregnancy outcomes
title_sort advanced maternal age: copy number variations and pregnancy outcomes
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308028/
https://www.ncbi.nlm.nih.gov/pubmed/37396033
http://dx.doi.org/10.3389/fgene.2023.1206855
work_keys_str_mv AT caoluoyuan advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT dongwenxu advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT wuqinjuan advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT huangxiaomin advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT zengxiaomei advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT yangjing advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT lujiaojiao advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT chenxunyan advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT zhengxian advancedmaternalagecopynumbervariationsandpregnancyoutcomes
AT fuxianguo advancedmaternalagecopynumbervariationsandpregnancyoutcomes